N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide

C82H101N11O3S3 — CID 23569765

IUPACN-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide
SMILESCCC(C)(C)c1ccc(Cc2ccc3nc(-n4nc(C(C)(C)C)c(C#N)c4/N=N/c4c(C)cc(N(c5nc6ccc(S(=O)(=O)NCCCOc7ccc(C(C)(C)CC)cc7C(C)(C)CC)cc6s5)c5c(C)cc(C)cc5C)nc4Nc4c(C)cc(C)cc4C)sc3c2)c(C(C)(C)CC)c1
InChIInChI=1S/C82H101N11O3S3/c1-23-79(15,16)58-30-29-57(62(45-58)81(19,20)25-3)43-56-28-33-64-67(44-56)98-77(86-64)93-75(61(48-83)73(91-93)78(12,13)14)90-89-71-53(9)42-69(87-74(71)88-70-51(7)38-49(5)39-52(70)8)92(72-54(10)40-50(6)41-55(72)11)76-85-65-34-32-60(47-68(65)97-76)99(94,95)84-36-27-37-96-66-35-31-59(80(17,18)24-2)46-63(66)82(21,22)26-4/h28-35,38-42,44-47,84H,23-27,36-37,43H2,1-22H3,(H,87,88)/b90-89+
InChIKeyVAZCXINDJFBSLN-ZOKRJXCSSA-N
MW1384.98 g/mol
LogP22.53
Rot. Bonds25

About N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide

N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide (PubChem CID 23569765) has the molecular formula C82H101N11O3S3 and a molecular weight of 1384.98 g/mol. Its IUPAC name is N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide.

Molecular Properties

Compound NameN-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide
PubChem CID23569765
Molecular FormulaC82H101N11O3S3
Molecular Weight1384.98 g/mol
Exact Mass1383.73
IUPAC NameN-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide
SMILESCCC(C)(C)c1ccc(Cc2ccc3nc(-n4nc(C(C)(C)C)c(C#N)c4/N=N/c4c(C)cc(N(c5nc6ccc(S(=O)(=O)NCCCOc7ccc(C(C)(C)CC)cc7C(C)(C)CC)cc6s5)c5c(C)cc(C)cc5C)nc4Nc4c(C)cc(C)cc4C)sc3c2)c(C(C)(C)CC)c1
InChIInChI=1S/C82H101N11O3S3/c1-23-79(15,16)58-30-29-57(62(45-58)81(19,20)25-3)43-56-28-33-64-67(44-56)98-77(86-64)93-75(61(48-83)73(91-93)78(12,13)14)90-89-71-53(9)42-69(87-74(71)88-70-51(7)38-49(5)39-52(70)8)92(72-54(10)40-50(6)41-55(72)11)76-85-65-34-32-60(47-68(65)97-76)99(94,95)84-36-27-37-96-66-35-31-59(80(17,18)24-2)46-63(66)82(21,22)26-4/h28-35,38-42,44-47,84H,23-27,36-37,43H2,1-22H3,(H,87,88)/b90-89+
InChIKeyVAZCXINDJFBSLN-ZOKRJXCSSA-N
XLogP22.53
TPSA175.67 Ų
H-Bond Donors2
H-Bond Acceptors15
Rotatable Bonds25
Heavy Atoms99
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001384.98
LogP ≤ 522.53
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}

Analyze N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide?
The IUPAC name of N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide (CID 23569765) is N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide.
What is the SMILES notation for N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide?
The canonical SMILES for N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide is CCC(C)(C)c1ccc(Cc2ccc3nc(-n4nc(C(C)(C)C)c(C#N)c4/N=N/c4c(C)cc(N(c5nc6ccc(S(=O)(=O)NCCCOc7ccc(C(C)(C)CC)cc7C(C)(C)CC)cc6s5)c5c(C)cc(C)cc5C)nc4Nc4c(C)cc(C)cc4C)sc3c2)c(C(C)(C)CC)c1.
What is the InChIKey of N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide?
The InChIKey is VAZCXINDJFBSLN-ZOKRJXCSSA-N. The full InChI is InChI=1S/C82H101N11O3S3/c1-23-79(15,16)58-30-29-57(62(45-58)81(19,20)25-3)43-56-28-33-64-67(44-56)98-77(86-64)93-75(61(48-83)73(91-93)78(12,13)14)90-89-71-53(9)42-69(87-74(71)88-70-51(7)38-49(5)39-52(70)8)92(72-54(10)40-50(6)41-55(72)11)76-85-65-34-32-60(47-68(65)97-76)99(94,95)84-36-27-37-96-66-35-31-59(80(17,18)24-2)46-63(66)82(21,22)26-4/h28-35,38-42,44-47,84H,23-27,36-37,43H2,1-22H3,(H,87,88)/b90-89+.
What are the key properties of N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide?
N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide has a molecular weight of 1384.98 g/mol, XLogP of 22.53, 25 rotatable bonds, 2 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[2,4-bis(2-methylbutan-2-yl)phenoxy]propyl]-2-(N-[5-[[1-[6-[[2,4-bis(2-methylbutan-2-yl)phenyl]methyl]-1,3-benzothiazol-2-yl]-3-tert-butyl-4-cyanopyrazol-5-yl]diazenyl]-4-methyl-6-(2,4,6-trimethylanilino)-2-pyridinyl]-2,4,6-trimethylanilino)-1,3-benzothiazole-6-sulfonamide is sourced from PubChem (CID 23569765), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).